Synthesis, crystal structure and antiproliferative evaluation of some new substituted benzothiazoles and styrylbenzothiazoles
The multistep synthesis of a series of new substituted-benzothiazoles as hydrochloride or quaternary salts is described. 6-Amidino substituted 2-aminobenzothiazoles ( 5, 6), N-methyl-2-(4-cyanostyryl)benzothiazolium iodide ( 8), cyano-substituted-2-styrylbenzothiazoles ( 9-11) and amidino and bis-am...
Saved in:
Published in: | Farmaco (Società chimica italiana : 1989) Vol. 59; no. 4; pp. 297 - 305 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
France
Elsevier SAS
01-04-2004
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The multistep synthesis of a series of new substituted-benzothiazoles as hydrochloride or quaternary salts is described. 6-Amidino substituted 2-aminobenzothiazoles (
5,
6), N-methyl-2-(4-cyanostyryl)benzothiazolium iodide (
8), cyano-substituted-2-styrylbenzothiazoles (
9-11) and amidino and bis-amidino-substituted 2-styrylbenzothiazoles (
12-17) were prepared. The crystal structure of amidino derivative (
6) was determined by single crystal X-ray analysis. All new prepared compounds were tested on the cytostatic activities against malignant cell lines: (SW620, colon carcinoma; Hep2, laryngeal carcinoma; HBL, melanoma; HeLa, cervical carcinoma and WI38, human normal fibroblasts). The compounds exerted a different inhibitory effect, depended on concentration and type of the cells. The best inhibitory effect was achieved with compounds (
12-15), with slight differences among them. All of them inhibited the growth of examined tumor cell lines and also normal fibroblasts. Other examined compounds exhibited a moderate inhibitory effect, depending on type of the cells. Majority of them inhibited the growth of HeLa cells and WI38. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0014-827X 1879-0569 |
DOI: | 10.1016/j.farmac.2004.01.008 |